camzyos 5 mg
bristol, myers squibb (israel) limited, israel - mavacamten - capsules - mavacamten 5 mg - mavacamten - camzyos is indicated for the treatment of adults with symptomatic new york heart association (nyha) class ii-iii obstructive hypertrophic cardiomyopathy (hcm) to improve functional capacity and symptoms
moniyot-131 oral solution 14,8-3700 mb oral opløsning
moniyot-131 capsule t 37-7400 mb kapsler, hårde
teiyo-200 200mg powder for injection (iv/im)
suhitas pharmaceuticals inc.; distributor: suhitas pharmaceuticals inc. - teicoplanin - powder for injection (iv/im) - 200mg
teiyo - 400 400mg powder for injection (iv/im)
suhitas pharmaceuticals inc.; distributor: suhitas pharmaceuticals inc. - teicoplanin - powder for injection (iv/im) - 400mg
ralzyo 1 mg/1 tab
الشركة المتحدة لصناعة الأدوية - united pharmaceutical manufacturing co. ltd. - rasagiline 1 mg/1 tab - 1 mg/1 tab
ralzyo 0.78 mg/1 tab
الشركة المتحدة لصناعة الأدوية - united pharmaceutical manufacturing co. ltd. - rasagiline 0.78 mg/1 tab - 0.78 mg/1 tab
camzyos™ 10mg 10mg/capsule
modern pharmaceutical company ireland - 28’s (14’s blister x 2) - capsule - 10mg/capsule - cardiovascular system-n/a
camzyos™ 15mg 15mg/capsule
modern pharmaceutical company ireland - 28’s (14’s blister x 2) - capsule - 15mg/capsule - cardiovascular system-n/a
camzyos™ 2.5mg 2.5mg/capsule
modern pharmaceutical company ireland - 28’s (14’s blister x 2) - capsule - 2.5mg/capsule - cardiovascular system-n/a